Dr. Mark A. Creager is a Professor of Medicine at Harvard Medical School and Senior Physician of the Cardiovascular Medicine Division, Director of the Vascular Center, and the Simon C. Fireman Scholar in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Creager earned his medical degree at Temple University in Philadelphia. He completed his internship, medical residency, and fellowships in Vascular Medicine and Cardiology at University Hospital in Boston.

Dr. Creager’s major research and clinical interests are in vascular medicine, specifically vascular regulatory mechanisms and the effect of treatment on patients with peripheral artery disease. His laboratory studies the effects of atherosclerosis and ricks factors for atherosclerosis, including hypercholesterolemia, diabetes, and hypertension, on endothelial function in humans. He is an editor of the textbook, Vascular Medicine, and the editor of the journals, Vascular Medicine and Current Treatment Options in Cardiovascular Medicine, a guest editor for Circulation and a member of the editorial board of Atherosclerosis, Thrombosis and Vascular Biology, and European Heat Journal. Dr. Creager is Past President of the Vascular Disease Foundation, Past President and Master of the Society for Vascular Medicine, and a Fellow of the American Heart Association, theAmericanCollege of Cardiology, and the American Physiological Society, and a member of the American Society of Clinical Investigation. He is the author of more than 300 published contributions to the medical literature, including research papers on vascular function and clinical trials of peripheral artery disease, book chapters, and monographs on vascular disease.

 

Selected publications:

Gasper WJ, Owens CD, Kim JM, Hills N, Belkin M, Creager MA, Conte MS. Early (30-day) vein remodeling is predictive of midterm graft patency after lower extremity bypass. J Vasc Surg. 2012; Epub ahead of print.

Bhatt DL, Paré G, Eikelboom JW, Simonsen KL, Emison ES, Fox KA, Steg PG, Montalescot G, Bhakta N, Hacke W, Flather MD, Mak KH, Cacoub P, Creager MA, Berger PB, Steinhubl SR, Murugesan G, Mehta SR, Kottke-Marchant K, Lincoff AM, Topol EJ; on behalf of the CHARISMA Investigators. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. Eur Heart J. 2012;33(17):2143-2150.

Owens CD, Kim JM, Hevelone ND, Gasper WJ, Belkin M, Creager MA, Conte MS. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease. J Vasc Surg. 2012;56(3):686-95.

Hiatt WR, Creager MA, Amato A, Brass EP.  Effect of propionyl-l-carnitine on a background of monitored exercise in patients with claudication secondary to PAD.  J Cardiopulm Rehabil Prev.  2011;31:125-132.

Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lüscher TF, Shechter M, Taddei S, Vita JA, Lerman A. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126(6):753-67.

Hiramoto JS, Owens CD, Kim JM, Boscardin J, Belkin M, Creager MA, Conte MS. Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts. J Vasc Surg. 2012;56(2):387-95; discussion 395.

 

For a complete list of Dr. Mark Creager’s publications, click here.